| __timestamp | Amphastar Pharmaceuticals, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 210461000 | 26551000 |
| Thursday, January 1, 2015 | 251519000 | 50286000 |
| Friday, January 1, 2016 | 255165000 | 81321000 |
| Sunday, January 1, 2017 | 240175000 | 159201000 |
| Monday, January 1, 2018 | 294666000 | 251247000 |
| Tuesday, January 1, 2019 | 322357000 | 306486000 |
| Wednesday, January 1, 2020 | 349846000 | 353874000 |
| Friday, January 1, 2021 | 437768000 | 365978000 |
| Saturday, January 1, 2022 | 498987000 | 401858000 |
| Sunday, January 1, 2023 | 644395000 | 482375000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, revenue growth is a key indicator of success. Over the past decade, Amphastar Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated have shown remarkable trajectories. Starting in 2014, Amphastar led with a revenue of $210 million, while Corcept trailed at $27 million. However, by 2023, Corcept's revenue surged to $482 million, marking an impressive 1,700% increase. Amphastar, not to be outdone, grew by 206%, reaching $644 million.
This growth reflects strategic advancements and market adaptability. Amphastar's consistent revenue increase highlights its robust product pipeline and market expansion. Meanwhile, Corcept's exponential growth underscores its successful niche focus and innovative therapies. As both companies continue to evolve, investors and industry watchers should keep a keen eye on their strategies and market movements. The next decade promises even more dynamic shifts in this ever-evolving sector.
Merck & Co., Inc. vs Corcept Therapeutics Incorporated: Examining Key Revenue Metrics
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Corcept Therapeutics Incorporated
Annual Revenue Comparison: Alnylam Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Annual Revenue Comparison: Catalent, Inc. vs Amphastar Pharmaceuticals, Inc.
Revenue Showdown: Sarepta Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.
Annual Revenue Comparison: Ascendis Pharma A/S vs Corcept Therapeutics Incorporated
Who Generates More Revenue? Lantheus Holdings, Inc. or Amphastar Pharmaceuticals, Inc.
Breaking Down Revenue Trends: Corcept Therapeutics Incorporated vs Perrigo Company plc
Corcept Therapeutics Incorporated vs Ligand Pharmaceuticals Incorporated: Annual Revenue Growth Compared
Comparing Revenue Performance: Corcept Therapeutics Incorporated or Dynavax Technologies Corporation?
Revenue Insights: ImmunityBio, Inc. and Amphastar Pharmaceuticals, Inc. Performance Compared